logo
Select company
Select metric
-42.75%Return on Assets
VS
Market
16
Sector
45
Industry
59
History
6
$ 6.49Close
$ 2 - $ 6.78 52-Week Range
Ticker Information

Ticker

RLAY

Company Name

RELAY THERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

RELAY THERAPEUTICS INC - Return on Assets Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

RLAY - ROA Historical data
DateTotal AssetsNet Income Common StockReturn on Assets
6/30/2025$ 728.84M$ -311.55M-42.75%
3/31/2025$ 799.36M$ -333.39M-41.71%
12/31/2024$ 871.3M$ -337.71M-38.76%
9/30/2024$ 930.12M$ -345.2M-37.11%
6/30/2024$ 772.55M$ -322.83M-41.79%
3/31/2024$ 841.44M$ -329.12M-39.11%
12/31/2023$ 843.98M$ -341.97M-40.52%
9/30/2023$ 906.96M$ -325.98M-35.94%
6/30/2023$ 962.02M$ -344.42M-35.8%
3/31/2023$ 1.04B$ -322.7M-31.1%
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • RELAY THERAPEUTICS INC's latest trailing twelve months (TTM) ROA stands at 0%.
  • Over the past 5 years, RELAY THERAPEUTICS INC's average ROA has been -36.85%.
  • The median ROA for RELAY THERAPEUTICS INC during this period was -37.11%
  • RELAY THERAPEUTICS INC reached its highest ROA over the past 5 years at -24.85%.
  • The lowest ROA recorded by RELAY THERAPEUTICS INC in the same timeframe -57.98%

RELAY THERAPEUTICS INC's ROA vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

ROA Benchmarks
CompanyROA
TSHA : TAYSHA GENE THERAPIES INC -27.82%DNTH : DIANTHUS THERAPEUTICS INC -35.19%TNXP : TONIX PHARMACEUTICALS HOLDING CORP -43.46%PRME : PRIME MEDICINE INC -71.42%PGEN : PRECIGEN INC -122.18%PRTA : PROTHENA CORP PUBLIC LTD CO -75.91%ABSI : ABSCI CORP -53.98%FATE : FATE THERAPEUTICS INC -46.15%TVRD : TVARDI THERAPEUTICS INC -47.76%PRAX : PRAXIS PRECISION MEDICINES INC -55.43%

Definition of Return on Assets

[Calculation] Return on Assets (ROA) measures net income [NetIncCmn] as percentage of total [Assets]. A high ROA shows an effective allocation of capital by the company.
Net Inc. Cmn. / Assets
(=) ROA
ROA for RELAY THERAPEUTICS INC is calculated as follows: Net Inc. Cmn. [ $ 0 ] / Assets [ $ 751.68M ]
(=) ROA [ 0% ]

RLAY - Return on Assets, Last 5 years

-57.98%

Minimum

Jun 30, 2021

-24.85%

Maximum

Sep 30, 2022

-36.85%

Average

-37.11%

Median

ROA Benchmark Analysis

The chart above depicts the distribution of ROA for companies in the Total Stock Market. The average ROA of the companies is 0.1% with a standard deviation of 10.63%.
The following table provides additional summary stats:
ROA in the Market:
filtered constituents3.45K
min-33.42%
max33.98%
average0.1%
median1.53%
std10.63%